Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 2/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10441612 | 0.94 | SIGMAR1 (0.46) | ESR2SIGMAR1CYP2C19LMNA | |
| SCHEMBL28803638 | 0.92 | SIGMAR1 (0.45) | ESR2SIGMAR1CYP2C19 | |
| SCHEMBL500650 | 0.92 | SIGMAR1 (0.45) | ESR2SIGMAR1CYP2C19 | |
| SCHEMBL7157124 | 0.92 | SIGMAR1 (0.45) | ESR2SIGMAR1CYP2C19 | |
| SCHEMBL28001899 | 0.92 | SIGMAR1 (0.45) | ESR2SIGMAR1CYP2C19 | |
| SCHEMBL10441856 | 0.92 | SIGMAR1 (0.45) | ESR2SIGMAR1CYP2C19 | |
| SCHEMBL1581793 | 0.92 | SIGMAR1 (0.45) | ESR2SIGMAR1CYP2C19 | |
| SCHEMBL27299341 | 0.92 | SIGMAR1 (0.45) | ESR2SIGMAR1CYP2C19 | |
| SCHEMBL3190448 | 0.89 | SIGMAR1 (0.47) | ESR2SIGMAR1ESR1CYP2C19LMNA | |
| SCHEMBL3200007 | 0.89 | CYP2C19 (0.50) | ESR2SIGMAR1CYP2C19LMNASLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025040241-A1 | A SUNSCREEN COMPOSITION | SYMRISE AG (DE) | 2025-02-27 | — | — | WO | disclosed |
| US-12221458-B2 | Organic borate-based catalyst, method for preparing isobutene oligomer using the same and isobutene oligomer prepared thereby | LG CHEM, LTD. (KR) | 2025-02-11 | — | — | US | disclosed |
| EP-4019128-B1 | ORGANIC BORATE-BASED CATALYST, METHOD FOR PREPARING ISOBUTENE OLIGOMER BY USING SAME, AND ISOBUTENE OLIGOMER PREPARED THEREBY | LG CHEMICAL LTD (KR) | 2024-02-21 | — | — | EP | disclosed |
| CN-113661185-B | Organoborate catalyst, process for producing isobutylene oligomer using the same, and isobutylene oligomer produced thereby | 株式会社LG化学 | 2023-12-29 | — | — | CN | disclosed |
| CN-115836061-A | Odorants and compositions comprising odorants | 丝趣科尔卡有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-115803309-A | Odorous compounds and methods of making the same | 丝趣科尔卡有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-115551829-A | Odorants and compositions comprising odorants | 丝趣科尔卡有限公司 | 2022-12-30 | — | — | CN | disclosed |
| CN-110494413-B | Compounds for reducing perception of malodour and uses thereof | 凯姆克姆公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-115003662-A | Odorants and compositions comprising odorants | 丝趣科尔卡有限公司 | 2022-09-02 | — | — | CN | disclosed |
| US-20220204533-A1 | Organic Borate-Based Catalyst, Method For Preparing Isobutene Oligomer Using The Same And Isobutene Oligomer Prepared Thereby | LG CHEM, LTD. (KR) | 2022-06-30 | — | — | US | disclosed |
| WO-2003031625-A1 | ESTERASE ESTA EXTRACTED FROM RHODOCOCCUS RUBER | DEGUSSA AG (DE) | 2003-04-17 | — | — | WO | disclosed |
| EP-1243580-A1 | HETEROCYCLIC IMINO COMPOUNDS AND FUNGICIDES AND INSECTICIDES FOR AGRICULTURAL AND HORTICULTURAL USE | Nissan Chemical Industries, Ltd. (JP) | 2002-09-25 | — | — | EP | disclosed |
| EP-0531715-B1 | Process for producing alcohols and ketones | SUMITOMO CHEMICAL CO (JP) | 1997-11-05 | — | — | EP | disclosed |
| US-5426237-A | Oxidation of straight, branched or cyclic alkanes and benzene derivatives in presence of transition metal catalyst and aldehyde | SUMITOMO CHEMICAL CO., LTD. (JP) | 1995-06-20 | — | — | US | disclosed |
| EP-0531715-A1 | Process for producing alcohols and ketones | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-03-17 | — | — | EP | disclosed |
| US-4650898-A | PERFUMES, FOODS, CHEWING GUMS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1987-03-17 | — | — | US | disclosed |
| US-4632831-A | GRAFEFRUIT-LIKE | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1986-12-30 | — | — | US | disclosed |
| US-4610812-A | Uses of methyl phenyl pentanol derivatives in augmenting or enhancing the aroma or taste of consumable materials | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1986-09-09 | — | — | US | disclosed |
| US-4131656-A | Intermediates for 5-(tertiary alkyl) resorcinol preparation | ELI LILLY AND COMPANY (US) | 1978-12-26 | — | — | US | disclosed |
| US-4087410-A | 5-(Tertiary alkyl) resorcinol preparation and intermediates therefor | ELI LILLY AND COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220204533-A1 | Organic Borate-Based Catalyst, Method For Preparing Isobutene Oligomer Using The Same And Isobutene Oligomer Prepared Thereby | OXER1, ORC3, OSBP | ESR2 2183/4885SIGMAR1 1037/4885KIF11 2578/4885 |
| US-12221458-B2 | Organic borate-based catalyst, method for preparing isobutene oligomer using the same and isobutene oligomer prepared thereby | OXER1, ORC3, OSBP | ESR2 2183/4885SIGMAR1 1037/4885KIF11 2578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.